WNV E Antikörper
-
- Target Alle WNV E Antikörper anzeigen
- WNV E (West Nile Virus Envelope (WNV E))
-
Reaktivität
- West Nile Virus (WNV)
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser WNV E Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Kreuzreaktivität
- West Nile Virus (WNV)
- Aufreinigung
- Purified by antigen-affinity chromatography.
- Immunogen
- Recombinant protein encompassing a sequence within the center region of West Nile virus Envelope protein (West Nile virus (strain NY99-IC)). The exact sequence is proprietary.
- Isotyp
- IgG
- Top Product
- Discover our top product WNV E Primärantikörper
-
-
- Applikationshinweise
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
- Kommentare
-
Positive Control: WNV-infected vero cell , WNV Envelope-transfected 293T cells , WNV-infected 293T
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1.38 mg/mL
- Buffer
- 1XPBS ( pH 7), 20 % Glycerol, 0.025 % ProClin 300
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
- Target
- WNV E (West Nile Virus Envelope (WNV E))
- Andere Bezeichnung
- West Nile virus Envelope (WNV E Produkte)
- Substanzklasse
- Viral Protein
- Hintergrund
- West Nile virus Envelope protein , WNV Envelope protein
- Molekulargewicht
- 54 kDa
-